Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bicycle Therapeutics plc - American Depositary Shares
(NQ:
BCYC
)
7.880
+0.070 (+0.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
268,297
Open
8.050
Bid (Size)
7.700 (2)
Ask (Size)
8.330 (20)
Prev. Close
7.810
Today's Range
7.750 - 8.060
52wk Range
6.100 - 25.77
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Bicycle Therapeutics Strengthens Board of Directors with New Appointments
September 08, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
4 Analysts Assess Bicycle Therapeutics: What You Need To Know
August 12, 2025
Via
Benzinga
Performance
YTD
-45.1%
-45.1%
1 Month
+4.0%
+4.0%
3 Month
-9.4%
-9.4%
6 Month
-6.4%
-6.4%
1 Year
-68.2%
-68.2%
More News
Read More
Bicycle (BCYC) Q2 Revenue Falls 69%
August 08, 2025
Via
The Motley Fool
Topics
Intellectual Property
Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results
August 08, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Deep Dive Into Bicycle Therapeutics Stock: Analyst Perspectives (9 Ratings)
February 26, 2025
Via
Benzinga
Forecasting The Future: 11 Analyst Projections For Bicycle Therapeutics
January 13, 2025
Via
Benzinga
Demystifying Bicycle Therapeutics: Insights From 7 Analyst Reviews
July 17, 2025
Via
Benzinga
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 03, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting
May 22, 2025
From
Bicycle Therapeutics
Via
Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 05, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
A Glimpse Into The Expert Outlook On Bicycle Therapeutics Through 7 Analysts
May 02, 2025
Via
Benzinga
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
May 01, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025
April 29, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Analyst Expectations For Bicycle Therapeutics's Future
April 09, 2025
Via
Benzinga
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 02, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
April 01, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments
March 27, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results
February 25, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 05, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 03, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones
January 13, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 09, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 03, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Frequently Asked Questions
Is Bicycle Therapeutics plc - American Depositary Shares publicly traded?
Yes, Bicycle Therapeutics plc - American Depositary Shares is publicly traded.
What exchange does Bicycle Therapeutics plc - American Depositary Shares trade on?
Bicycle Therapeutics plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Bicycle Therapeutics plc - American Depositary Shares?
The ticker symbol for Bicycle Therapeutics plc - American Depositary Shares is BCYC on the Nasdaq Stock Market
What is the current price of Bicycle Therapeutics plc - American Depositary Shares?
The current price of Bicycle Therapeutics plc - American Depositary Shares is 7.880
When was Bicycle Therapeutics plc - American Depositary Shares last traded?
The last trade of Bicycle Therapeutics plc - American Depositary Shares was at 10/24/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.